Shopping Cart
- Remove All
- Your shopping cart is currently empty
STAT5-IN-3 (Compound 14a) is a STAT5 inhibitor with anticancer properties. It works by blocking the tyrosine phosphorylation of STAT5A/5B at the Y694/699 sites, significantly reducing the expression of the STAT5B protein. This leads to the inhibition of downstream gene transcription, thereby preventing the proliferation and survival of leukemia cells. Additionally, STAT5-IN-3 has significant potential in overcoming chemotherapy resistance.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | STAT5-IN-3 (Compound 14a) is a STAT5 inhibitor with anticancer properties. It works by blocking the tyrosine phosphorylation of STAT5A/5B at the Y694/699 sites, significantly reducing the expression of the STAT5B protein. This leads to the inhibition of downstream gene transcription, thereby preventing the proliferation and survival of leukemia cells. Additionally, STAT5-IN-3 has significant potential in overcoming chemotherapy resistance. |
In vitro | STAT5-IN-3 (Compound 14a), at concentrations ranging from 100 nM to 10 μM over 48 hours, effectively inhibits the activity of myeloid leukemia cells (KU812, K562, KCL-22, MV-4-11, and MOLM-13) with EC50 values of 0.6 μM, 0.8 μM, 0.5 μM, 0.3 μM, and 0.3 μM, respectively. In contrast, it exhibits lower toxicity towards normal cells (HS27A and MSC), with EC50 values exceeding 10 μM [1]. |
Molecular Weight | 413.51 |
Formula | C25H27N5O |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.